Camtek Ltd. (CAMT) Stock Price & Analysis
Camtek Ltd. (CAMT) closed at USD 119.48 on Thursday, October 22, 2026, down 10.23% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 133.09; the Oct 22, 2026 session ranged USD 117.67–125.77 on volume of 609,352 shares. Market capitalization is $5.58B, with a 52-week range of USD 91.91–215.99 (NGM). Source: Nexqual, retrieved October 23, 2026 at 09:55 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CAMT.md
Key facts (CAMT)
- 2 of 80 tracked superinvestors hold CAMT (13F, Q2 2026): 2 new, 0 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 7 Form 4 filings, $5.1M; 7 not under a Rule 10b5-1 plan ($5.1M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 2.25 on a 1–5 scale) (12 analysts), mean target USD 172.8 (range 152–200).
- Total return with dividends: 1Y +1.2% vs S&P 500 +14.9%; 5Y +209.3% vs S&P 500 +80.3%.
- Next earnings: 2026-11-04, EPS estimate USD 0.99, revenue estimate $161M.
Superinvestors (SEC 13F-HR, Q2 2026) (CAMT)
2 of 80 tracked investors hold CAMT. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Polen Capital | Polen Capital Management | 0.01% | $671K | New position |
| Lee Ainslie | Maverick Capital | 0.01% | $589K | New position |
Insider sales (SEC Form 4, open-market, last ~7 months) (CAMT)
0 of 7 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-08-17 | Geva-Dvash Orit | Vice President, HR | 508 | $89K | 8.9% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-08-13…2026-08-14 | Andorn Karni Yarl | Director | 5,532 | $928K | 80.5% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-08-13 | Langer Ram | Chief Operating Officer | 6,387 | $1.1M | 26.7% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-08-13 | Amit Rafi | Chief Executive Officer | 6,250 | $1.1M | 10.1% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-08-12 | Geva-Dvash Orit | Vice President, HR | 415 | $72K | 6.8% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-08-11…2026-08-12 | Aviram Lior | Director | 6,694 | $1.1M | 34.8% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-08-11…2026-08-12 | Eisenberg Moshe | Chief Financial Officer | 4,404 | $713K | 21.3% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (CAMT)
Consensus Buy (mean 2.25 on a 1–5 scale), 12 analysts; mean target USD 172.8 (low 152, high 200).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-20 | B. Riley Securities | Target lowered | Buy | $200 → $166 |
| 2026-10-16 | Needham | Target lowered | Buy | $190 → $170 |
| 2026-09-28 | Morgan Stanley | Target lowered | Equal-Weight | $165 → $152 |
| 2026-08-11 | Morgan Stanley | Target lowered | Equal-Weight | $167 → $165 |
| 2026-07-06 | Morgan Stanley | Target raised | Equal-Weight | $163 → $167 |
Total return (dividends reinvested) (CAMT)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +1.2% | +209.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +1.2% | +25.3% |
| Volatility (annualized) | 71.0% | 54.2% |
| Max drawdown | -42.4% (May 2026→Oct 2026) | -61.8% (Jul 2024→Mar 2025) |
CAMT suppliers, customers and competitors (named in its 20-F)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Priortech | “We also entered into a Second Amended and Restated Registration Rights Agreement with Priortech and Chroma, according” |
| Partner | Chroma ATE | “We also entered into a Second Amended and Restated Registration Rights Agreement with Priortech and Chroma, according” |
Quoted from the company's 20-F filed Mar 19, 2026.
CAMT analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.99 | $0.93 | +6.4% | $160.6M | 10 |
| Next quarter (ends Dec 2026) | $1.17 | $1.11 | +4.9% | $180.0M | 9 |
| Current fiscal year (ends Dec 2026) | $3.63 | $3.50 | +3.7% | $595.4M | 10 |
| Next fiscal year (ends Dec 2027) | $5.08 | $4.48 | +13.4% | $800.9M | 10 |
CAMT options: expected move
Options price a move of about ±18.2% (±$21.80) by Nov 20, 2026, which includes earnings on Nov 4, 2026.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 81.1% | ±18.2% |
| Dec 18, 2026 | 56 | 74.7% | ±23.5% |
| Jan 15, 2027 | 84 | 73.2% | ±28.1% |
| Feb 19, 2027 | 119 | 72.3% | ±32.7% |
| May 21, 2027 | 210 | 69.4% | ±41.1% |
30-day implied volatility 80.6% vs 64.8% realized over the last 30 trading days. Put/call ratio (volume) 0.22. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:55 UTC)
| Price | USD 119.48 |
|---|---|
| Change | ▼ 10.23% (down) |
| Previous Close | USD 133.09 |
| Open | USD 125 |
| Day Range | USD 117.67 – 125.77 |
| 52-Week Range | USD 91.91 – 215.99 |
| Volume | 609,352 shares |
| Market Cap | $5.58B |
| Exchange | NGM |
Technical Analysis (CAMT)
Nexqual's technical model rates CAMT "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 09:55 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 31.59 (neutral) |
| vs SMA50 | Below (USD 145.4) |
| MACD | -5.77 (negative) |
Analyst Ratings (CAMT)
Wall Street analysts rate CAMT "Buy" based on 12 analysts, with a mean price target of USD 172.8 (range USD 152–200), per Nexqual as of October 23, 2026 at 09:55 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 12 |
| Mean Target | USD 172.8 |
| High Target | USD 200 |
| Low Target | USD 152 |
| Buy / Hold / Sell | 7 / 5 / 0 |
Earnings (CAMT)
| Next Earnings Date | 2026-11-04 |
|---|---|
| EPS Estimate | USD 0.99 |
| Revenue Estimate | $160.57M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.78 vs est 0.76 ▲ beat |
| 2026-03-31 | USD 0.7 vs est 0.68 ▲ beat |
| 2025-12-31 | USD 0.81 vs est 0.81 ▼ miss |
| 2025-09-30 | USD 0.82 vs est 0.8 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:55 UTC.
Financials & Fundamentals (CAMT)
| Total Revenue | $499.09M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +2.50% |
| Gross Margin | +50.97% |
| Operating Margin | +22.41% |
| Profit Margin | +9.63% |
| ROE | +7.56% |
| Debt / Equity | 0.71 |
| Current Ratio | 8.35 |
| Total Cash | $670.26M |
| Total Debt | $487.81M |
Source: Nexqual, October 23, 2026 at 09:55 UTC.
Financial Health Score (CAMT)
Nexqual rates Camtek Ltd.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:55 UTC.
| Growth | Strong — Revenue +16% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 51%, operating 22% (last 12 months) |
| Balance Sheet | Strong — $670M cash vs $488M debt, net cash position |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — ROE 8%, ROA 7.1% |
Ownership (CAMT)
| Insider Ownership | +37.47% |
|---|---|
| Institutional Ownership | +52.14% |
| Shares Outstanding | 46.67M |
| Float | 28.24M |
| Short % of Float | +8.66% |
Source: Nexqual, October 23, 2026 at 09:55 UTC.
Leadership (CAMT)
Camtek Ltd. is led by Rafi Amit, CEO & Director, per Nexqual as of October 23, 2026 at 09:55 UTC.
| CEO & Director | Rafi Amit |
|---|---|
| Executive Chairman of the Board | Lior Aviram |
| Chief Financial Officer | Moshe Eisenberg |
| Chief Operating Officer | Ramy Langer |
| Vice President of Human Resources | Orit Geva Dvash |
Major Backers & Investors (CAMT)
Notable institutional backers of Camtek Ltd. include Migdal Insurance & Financial Holdings Ltd., Harel Insurance Investments & Financial Services Ltd., Menora Mivtachim Holdings Ltd., according to Nexqual as of October 23, 2026 at 09:55 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Migdal Insurance & Financial Holdings Ltd. | 5.68% |
| Harel Insurance Investments & Financial Services Ltd. | 4.77% |
| Menora Mivtachim Holdings Ltd. | 4.5% |
| Clal Insurance Enterprises Holdings Ltd | 4.04% |
| Wasatch Advisors LP | 3.16% |
| Jane Street Group, LLC | 1.92% |
| Y.D. More Investments Ltd | 1.71% |
| WASATCH FUNDS TRUST-Wasatch Core Growth Fund | 1.53% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.74% |
Source: Nexqual, October 23, 2026 at 09:55 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FORM | FormFactor, Inc. | USD 95.03 | ▼ 15.29% |
| KLIC | Kulicke and Soffa Industries, I | USD 73.4 | ▼ 9.86% |
| AXTI | AXT Inc | USD 51.56 | ▼ 13.02% |
| ACMR | ACM Research, Inc. | USD 49.12 | ▼ 10.18% |
| NVMI | Nova Ltd. | USD 310.13 | ▼ 6.37% |
| ACLS | Axcelis Technologies, Inc. | USD 104.74 | ▼ 10.16% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:55 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt